Johnson Pharmacare Ltd — Important, 16-02-2026: Company Update

JOHNSON PHARMACARE LIMITED has submitted its unaudited financial results for the quarter and nine months ended December 31, 2025. The company reported zero operational income for both periods. It posted a net loss after tax of ₹0.064 Cr for the quarter and ₹0.0706 Cr for the nine months. Earnings per share remained at ₹0.00 (loss) for both periods. These figures highlight continued losses and a lack of revenue generation, which are key points for shareholders to note.